English 箭头
Podcast Cover

[Exploring the Secrets of Human Longevity and the Future of Magnetically Controlled Proteins]-[Briefing Chat: What Brazilian centenarians could reveal about the science of ageing]

Nature Podcast · B2 · 2026-01-30

Technology
Or study on the web version

📋 Summary

Unlocking the Secrets of Exceptional Longevity: The DNA Longevo Study

Recent scientific investigations into human aging have shed light on the mysteries of why some individuals live well into their second century. The DNA Longevo (long-lived DNA) study in Brazil is currently at the forefront of this research, having already sequenced the genomes of over 160 centenarians and 20 supercentenarians—individuals who have surpassed 110 years of age. Unlike many previous studies that focused on genetically homogeneous populations, this research highlights the importance of genetic diversity, noting that many participants possess a mixed ancestry of European, African, and Native American descent. Researchers hypothesize that this diversity may contribute to the "resilience" observed in these participants.

One of the most striking aspects of this cohort is that their longevity does not appear to be the result of privileged lifestyles. The study notes that many participants lacked access to "high-end medicine" and did not follow strict "exercise regimes" or healthy diets. Their survival in remote areas, away from major medical centers, suggests that their longevity is driven by biological factors rather than external medical interventions. Anecdotal evidence, such as a 106-year-old woman who took up swimming in her 70s and a 107-year-old man who remains an active worker, underscores the physical vitality present in these supercentenarians. As the study continues, researchers are comparing these genomes to biobanks of individuals who died at younger ages, while also establishing new "immunological profiles" and "biomarkers" to define what constitutes normal aging for this resilient group.

Pioneering Magnetically Controlled Proteins: A New Frontier in Biotechnology

In a separate, equally groundbreaking area of research, scientists are exploring the potential of using magnetic fields to control proteins at a molecular level. Building upon the discovery that the widely used "green fluorescent protein" (GFP) is slightly sensitive to magnetic fields, researchers have developed new, highly responsive variants. The most notable of these is "MagLOV," a protein engineered to dim by approximately 50% when exposed to a magnetic field. This development represents a significant leap from the original 1% sensitivity observed in basic GFP, allowing researchers to detect and manipulate specific proteins from a distance.

This "proof of principle" technology holds immense potential for future medical and biological applications. By utilizing "directed evolution"—a process involving repeated mutations to guide a protein toward a desired outcome—scientists are creating tools that can be switched on or off remotely. Beyond fluorescent proteins, researchers are developing "mag bodies," which are antibodies whose binding strength can be modulated by magnets. This could eventually allow for precise control over how proteins bind to cell surfaces. While current experiments have been confined to "E. coli" and early tests in "C. elegans," the ability of magnets to penetrate tissues suggests a future where this technology could monitor cellular processes in living organisms, offering a non-invasive way to guide therapies to where they are needed most.

🎯Key Sentences

1
I'm doing well, Ben.
2
shines a light on some new research.
3
Well, that has baited the hook, I shall say.
4
it's of huge interest to a lot of researchers as well.
5
hopefully their genetics can tell us something about how they got there.
Expand All

📝Key Phrases

1
shines a light on
2
baited the hook
3
sets this cohort apart
4
fill a gap
5
off the bat
Expand All

📖 Transcript

Hi listeners, Benjamin here.
Welcome to the Nature Briefing podcast, the Friday show where we talk about a couple of stories we have read in the Nature Briefing, which is, of course, Nature's daily roundup of the latest science stories.
We're actually recording this in the office today, so you might hear a few folk walk past.
But one of the folk who hasn't walked past and is here to talk science with me is Nick Petrichow.
Nick, how are you doing today?
I'm doing well, Ben.

ListenLeap Brings You Into Real Context Learning

🎨 Interesting Content
🌍 Real Materials
📱 Listen Anytime
Or study on the web version